- Discussion
18- 10.1182/bloodadvances.2018028282
Long-term follow-up of a phase 3 clinical trial of inolimomab for the treatment of primary steroid refractory aGVHD
- Jan 22, 2019
- Blood Advances
- Gérard Socié + 12 more +12
Cherry Biotech (France)
Recent publications and citations
Top Concepts
Top subject area publications in last 5 years
Collaboration Analysis
Publications from 2021 to 2026
Latest Publications
Filter 